Jouët Pauline, Sabaté Jean-Marc, Maillard Dominique, Msika Simon, Mechler Charlotte, Ledoux Séverine, Harnois Florence, Coffin Benoit
Service d'Hépato-Gastroentérologie, AP-HP Hôpital Louis Mourier, Colombes, France.
Obes Surg. 2007 Apr;17(4):478-85. doi: 10.1007/s11695-007-9085-3.
Morbid obesity is a risk factor of nonalcoholic steatohepatitis (NASH). Obstructive sleep apnea (OSA) could also be an independent risk factor for elevated liver enzymes and NASH. The relationships between liver injuries and OSA in morbidly obese patients requiring bariatric surgery were studied prospectively.
Every consecutive morbidly obese patient (BMI > or =40 kg/m2 or > or =35 kg/m2 with severe comorbidities) requiring bariatric surgery was included between January 2003 and October 2004. Polygraphic recording, serum aminotransferases (ALT, AST), gamma-glutamyltransferase (GGT) and liver biopsy were systematically performed. OSA was present when the apnea-hypopnea index (AHI) was >10/h.
62 patients (54 F; age 38.5 +/- 11.0 (SD) yrs; BMI 47.8 +/- 8.4 kg/m2) were included. Liver enzymes (AST, ALT or GGT) were increased in 46.6%. NASH was present in 34.4% and OSA in 84.7%. Patients with OSA were significantly older (P = 0.015) and had a higher BMI (P = 0.003). In multivariate analysis, risk factors for elevated liver enzymes were the presence of OSA and male sex. The presence of NASH was similar in patients with or without OSA (32.7% vs 44.4% of patients, P = 0.76).
In this cohort of morbidly obese patients requiring bariatric surgery, one-third of patients had NASH, a prevalence similar to previous studies. OSA was found to be a risk factor for elevated liver enzymes but not for NASH.
病态肥胖是非酒精性脂肪性肝炎(NASH)的一个危险因素。阻塞性睡眠呼吸暂停(OSA)也可能是肝酶升高和NASH的独立危险因素。对需要进行减肥手术的病态肥胖患者的肝损伤与OSA之间的关系进行了前瞻性研究。
纳入2003年1月至2004年10月期间每一位需要进行减肥手术的连续病态肥胖患者(体重指数[BMI]≥40kg/m²或≥35kg/m²且伴有严重合并症)。系统地进行多导睡眠图记录、血清转氨酶(ALT、AST)、γ-谷氨酰转移酶(GGT)和肝活检。当呼吸暂停低通气指数(AHI)>10次/小时时存在OSA。
纳入62例患者(54例女性;年龄38.5±11.0[标准差]岁;BMI 47.8±8.4kg/m²)。46.6%的患者肝酶(AST、ALT或GGT)升高。34.4%的患者存在NASH,84.7%的患者存在OSA。OSA患者年龄显著更大(P=0.015)且BMI更高(P=0.003)。在多变量分析中,肝酶升高的危险因素是存在OSA和男性性别。有或无OSA的患者中NASH的存在情况相似(分别为32.7%和44.4%的患者,P=0.76)。
在这组需要进行减肥手术的病态肥胖患者中,三分之一的患者患有NASH,患病率与先前研究相似。发现OSA是肝酶升高的危险因素,但不是NASH的危险因素。